Exact Mass: 433.2001

Exact Mass Matches: 433.2001

Found 10 metabolites which its exact mass value is equals to given mass value 433.2001, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

Belotecan

19-ethyl-19-hydroxy-10-{2-[(propan-2-yl)amino]ethyl}-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione

C25H27N3O4 (433.2001)


   

Belotecan

Belotecan

C25H27N3O4 (433.2001)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01C - Plant alkaloids and other natural products > L01CE - Topoisomerase 1 (top1) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059004 - Topoisomerase I Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D004791 - Enzyme Inhibitors

   

(2R)-N-Hydroxy-2-[(3S)-3-methyl-3-{4-[(2-methylquinolin-4-YL)methoxy]phenyl}-2-oxopyrrolidin-1-YL]propanamide

(2R)-N-Hydroxy-2-[(3S)-3-methyl-3-{4-[(2-methylquinolin-4-YL)methoxy]phenyl}-2-oxopyrrolidin-1-YL]propanamide

C25H27N3O4 (433.2001)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

4-[(4-benzylpiperazin-1-yl)acetyl]-9-hydroxy-1,2,3,4-tetrahydro-5H-chromeno[3,4-b]pyridin-5-one

4-[(4-benzylpiperazin-1-yl)acetyl]-9-hydroxy-1,2,3,4-tetrahydro-5H-chromeno[3,4-b]pyridin-5-one

C25H27N3O4 (433.2001)


   

2-(2-ethyl-6-methyl-3-oxo-1,4-benzoxazin-4-yl)-N-[(5-methyl-2-furanyl)methyl]-N-(3-pyridinylmethyl)acetamide

2-(2-ethyl-6-methyl-3-oxo-1,4-benzoxazin-4-yl)-N-[(5-methyl-2-furanyl)methyl]-N-(3-pyridinylmethyl)acetamide

C25H27N3O4 (433.2001)


   

N-[(E)-(2-hydroxynaphthalen-1-yl)methylideneamino]-N-(2-hydroxyphenyl)octanediamide

N-[(E)-(2-hydroxynaphthalen-1-yl)methylideneamino]-N-(2-hydroxyphenyl)octanediamide

C25H27N3O4 (433.2001)


   

(2S,3S,3aR,9bR)-1-acetyl-7-(1-cyclopentenyl)-3-(hydroxymethyl)-6-oxo-N-phenyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

(2S,3S,3aR,9bR)-1-acetyl-7-(1-cyclopentenyl)-3-(hydroxymethyl)-6-oxo-N-phenyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C25H27N3O4 (433.2001)


   

(2R,3R,3aS,9bS)-1-acetyl-7-(1-cyclopentenyl)-3-(hydroxymethyl)-6-oxo-N-phenyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

(2R,3R,3aS,9bS)-1-acetyl-7-(1-cyclopentenyl)-3-(hydroxymethyl)-6-oxo-N-phenyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C25H27N3O4 (433.2001)


   

N-benzoyl-L-valylglycine 4-methoxy-2-naphthylamide

N-benzoyl-L-valylglycine 4-methoxy-2-naphthylamide

C25H27N3O4 (433.2001)


   

(3R,8aS)-2,2,9,9-tetramethyl-10-oxidospiro[6,7,8,8a-tetrahydro-2H-pyrrolo[1,2-a]pyrazine-3,7-8H-pyrano[2,3-b]carbazol-10-ium]-1,4-dione

(3R,8aS)-2,2,9,9-tetramethyl-10-oxidospiro[6,7,8,8a-tetrahydro-2H-pyrrolo[1,2-a]pyrazine-3,7-8H-pyrano[2,3-b]carbazol-10-ium]-1,4-dione

C25H27N3O4 (433.2001)